PharmaLundensis
0.20 SEK
-6.10 %
Less than 1K followers
PHAL
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for PharmaLundensis
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| EBITDA | -0.6 | -0.8 | -2.2 | -1.1 | -1.7 | -1.4 | -1.6 | -5.8 |
| EBIT | -0.9 | -1.1 | -3.3 | -1.4 | -2.0 | -1.6 | -1.9 | -6.9 |
| EBIT-% | ||||||||
| Profit before taxes | -1.0 | -1.2 | -3.9 | -1.5 | -2.1 | -1.7 | -1.9 | -7.1 |
| Net income | -1.0 | -1.2 | -3.9 | -1.5 | -2.1 | -1.7 | -1.9 | -7.1 |